Breaking News

West to Unveil DeltaCube and New NovaGuard SA at INTERPHEX

DeltaCube Platform aims to aid decisions for container closure systems and NovaGuard SA Pro safety system expanded for ISO standard 0.5mL glass syringes.

By: Kristin Brooks

Managing Editor, Contract Pharma

West Pharmaceutical Services, Inc., a global provider of solutions for injectable drug administration, will unveil its DeltaCube Modeling Platform and the new NovaGuard SA Pro Safety System for ISO 0.5mL Standard Glass Syringes at Interphex booth 1861 in New York City, form October 19 – 21.
 
The DeltaCube Modeling Platform is an online vial integrity modeling platform designed to help developers make informed decisions about container closure systems. Using a big data approach and West’s packaging and testing experience, the DeltaCube Modeling Platform is designed to provide an efficient tool to guide vial, stopper and seal combination development. The DeltaCube also supports the troubleshooting of defects or container closure integrity failures due to component dimensional issues.
 
“The DeltaCube concept originated to address a series of customer challenges in order to have a deeper understanding of why the issues were occurring,” said Fran DeGrazio, Chief Scientific Officer. “It is the first modeling solution that takes previously underutilized data and turns it into a valuable tool for our customers. We are the first to meet customers on this path with the goal of simplifying their journey through successful development and commercialization.”
 
Also, the NovaGuard SA Pro safety system product line has been expanded to include a new device for ISO standard 0.5mL glass syringes. The new 0.5mL device leverages the same NovaGuard SA Pro technology and will be marketed alongside the ISO 1mL long glass staked needle syringe system to address a broader set of customers’ dosage needs with pre-filled syringes (PFS). This new size provides a much-needed product offering for customers needing a safety device for their 0.5mL ISO standard glass PFS drug products as the analysis of the pre-filled syringe market indicates that most drugs that use pre-filled syringes deliver doses between 0.1mL and 1.0mL fill volumes.
 
“This new product expansion comes at an opportune time for West. As a product with innovative safety features that help protect healthcare workers and patients from accidental needlestick injuries, the NovaGuard SA Pro safety system can be deployed using a single-handed technique and is designed to prevent pre-activation during handling,” said David Maier, VP, GM, Generics. “Furthermore, the device design facilitates easy assembly of a glass pre-filled syringe with minimal change parts and changeover time needed to existing assembly equipment lines at customer facilities.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters